Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Artificial Intelligence Helps Diagnose Cardiac Infections

By HospiMedica International staff writers
Posted on 22 Sep 2009
Researchers reported that "teachable software" designed to mimic the human brain may help them identify cardiac infections without an invasive exam. More...


The study's findings were presented by investigators from the Mayo Clinic (Rochester, MN, USA) in September 2009 at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, CA, USA.

Endocarditis, an infection involving the valves and sometimes chambers of the heart, can be a problem in patients with implanted medical devices. It is serious and can be deadly. The mortality rate can be as high as one in five, even with aggressive treatment and removal of the device. With further complications, the mortality could be over 60%. Diagnosis typically requires transesophageal echocardiography, an invasive procedure that also has risks. It involves use of an endoscope and insertion of a probe down the esophagus.

The software program, called an artificial neural network because it mimics the brain's cognitive function and reacts differently to situations depending on its accumulated experience, is made of programs that mimic interconnected artificial neurons. That knowledge or training is provided by the researchers by affecting the connection weights of the artificial neurons; similar to how a person would train a dog by repetition, reinforcing behavior at each instance. In this case, the neural net underwent three separate "trainings" to learn how to evaluate the symptoms it would be considering.

"If, through this novel method, we can help determine a percentage of endocarditis diagnoses with a high rate of accuracy, we hope to save a significant number of patients from the discomfort, risk, and expense of the standard diagnostic procedure," said M. Rizwan Sohail, M.D., a Mayo Clinic infectious diseases specialist and leader of the study.

The team examined 189 Mayo patients with device-related endocarditis diagnosed between 1991 and 2003. The artificial neural network was tested retrospectively on the data from these cases. When tested on cases with known diagnosis of endocarditis, the best-trained artificial neural network was correct most of the time (72 of 73 implant-related infections, and 12 of 13 endocarditis cases) with a confidence level greater than 99%.

Researchers reported that, when used on an overall sample that included both known and unknown cases, the neural net accurately excluded endocarditis in at least half of the cases, thereby eliminating half the cohort from a needless invasive procedure.

Related Links:

Mayo Clinic



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Hemostatic Agent
HEMOBLAST Bellows
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.